Management of Narcolepsy and Excessive Daytime Sleepiness

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Latest News

Migraine Frequency and Aura Impacts Sensory Organization

AbbVie Submits NDA for ABBV-951, Periconceptional Folic Acid Supplementation Lowers Preterm Birth Risk, FDA Accepts NDA for Zavegepant

NeurologyLive® Friday 5 — May 27, 2022

Neurology on the Hill 2022: Takeaways and Progress

View More News

Management of Narcolepsy and Excessive Daytime Sleepiness

EP. 1: Overview of Excessive Daytime Sleepiness

EP. 2: Overview of Narcolepsy

EP. 3: Signs and Symptoms of Narcolepsy

EP. 4: Narcolepsy Type 1 and Type 2

EP. 5: Diagnosis of Narcolepsy

EP. 6: Goals of Therapy in Narcolepsy

EP. 7: Nonpharmacologic Therapies for Narcolepsy

EP. 8: Laboratory Testing in Patients with Narcolepsy

EP. 9: Traditional Treatments for Narcolepsy

EP. 10: Pitolisant: Recently FDA Approved for Narcolepsy

Latest News